Efficacy and safety of Dabrafenib in Erdheim-Chester disease
Abstract This study evaluates the efficacy and safety of dabrafenib in BRAF V600E mutant Erdheim-Chester disease (ECD). This retrospective study reviewed patients who received dabrafenib treatment for at least one month at Peking Union Medical College Hospital and the Cancer Hospital of the Chinese...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Springer
2025-11-01
|
| Schriftenreihe: | Annals of Hematology |
| Schlagworte: | |
| Online-Zugang: | https://doi.org/10.1007/s00277-025-06707-1 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|
